KMTS as reported
Kestra Medical Technologies, Ltd. reported $95M of revenue over the trailing twelve months. 10 reported series are charted on this page, each one as filed.
$95M
Revenue, trailing twelve months · to Q4 2026 · every figure below is as filed, with no scoring applied
- Net Income
- −$132M
Net Income · trailing twelve months to Q4 2026
- Free Cash Flow
- −$117M
Free Cash Flow · trailing twelve months to Q4 2026
- Op Margin
- −142%
Op Margin · trailing twelve months to Q4 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $95M | n/a | Q4 2026 |
| Net Income | −$132M | n/a | Q4 2026 |
| EPS | −$2.42 | n/a | Q4 2026 |
| Gross Margin | 51% | n/a | Q4 2026 |
| Op Margin | −142% | n/a | Q4 2026 |
| Net Margin | −138% | n/a | Q4 2026 |
| ROE | −62% | n/a | Q4 2026 |
| ROA | −43% | n/a | Q4 2026 |
| ROIC | −276% | n/a | Q4 2026 |
| Free Cash Flow | −$117M | n/a | Q4 2026 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Kestra Medical Technologies, Ltd. (KMTS) - Revenue & ProfitRevenue & ProfitKestra Medical Technologies, Ltd. (KMTS)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Instruments & Supplies
Ranks #26 of 27 by Smart Score